Medically Reviewed by Dr. Kim Langdon Cull, MD, Written by Dr. Jyothi Shenoy, MD
Menopause represents a significant milestone in a woman’s life by signaling the end of menstruation and fertility. The journey to menopause can take several years, and despite this transition, contraceptive considerations remain important during the years leading up to menopause. Many women incorrectly assume they don’t need birth control when perimenopausal symptoms start, but this assumption can lead to unintended pregnancies.
This article provides an overview of how hormonal changes in the perimenopausal phase can influence fertility, the range of birth control options available, and when it may be appropriate to discontinue contraception. By understanding the relationship between menopause and contraception, you can make informed decisions that support both reproductive and overall health.
How Menopause Affects Contraception
Menopause is officially diagnosed after 12 consecutive months without a menstrual period. Yet the transition to this stage, known as perimenopause, can last for several months or even over a decade. The information in this section highlights why birth control continues to be relevant until menopause is confirmed.
Perimenopause and Irregular Ovulation
During perimenopause, ovulation becomes unpredictable, which means pregnancy remains possible. Many women experience fluctuating menstrual cycles and might mistakenly assume they are no longer fertile if they go months without a period.
Even if you do not have a period for an extended time, sporadic ovulation may still occur, raising the possibility of unintended pregnancy. Therefore, continuing contraception until menopause is confirmed is generally advised.
Changes in Hormone Levels
Perimenopause involves significant fluctuations in estrogen and progesterone. These changes can influence how the body responds to hormonal contraceptives, often leading to side effects such as:
- Migraines or headaches
- Mood swings
- Breast tenderness
- Irregular spotting
In addition, lowered estrogen levels can cause vaginal dryness, which may make barrier methods (like condoms) uncomfortable unless paired with lubricants.
Increased Risk of Blood Clots and Cardiovascular Issues
Advancing age brings a heightened risk of blood clots, high blood pressure, and other cardiovascular conditions. Certain hormonal contraceptives—particularly combination birth control pills containing estrogen—may further increase these risks, especially in women who smoke or have a history of clotting disorders.
Women over 40, especially those with additional risk factors (e.g., high blood pressure or obesity), may consider non-hormonal or progestin-only contraceptive options to reduce potential complications.
Understanding how shifting hormones and health risks evolve during perimenopause can help guide safer and more effective contraceptive choices.
What Are Your Contraceptive Options During Menopause?
Before you reach confirmed menopause, a range of contraceptive methods can prevent unintended pregnancy and even alleviate some perimenopausal symptoms. This section examines different contraceptive types, their benefits, and their potential drawbacks, helping you choose what best fits your health status and personal preferences.
Combined Hormonal Contraceptives (Pills, Patch, or Ring)
These methods contain both estrogen and progestin, offering the following advantages:
- Pregnancy prevention
- Regulation of irregular periods
- Reduction of heavy bleeding and cramping
- Alleviation of perimenopausal symptoms such as hot flashes and acne
- Vaginal rings can be particularly beneficial for women who prefer avoiding a daily pill regimen or are forgetful about taking pills consistently
Combined hormonal methods may also lower the risk of endometrial, ovarian, and colorectal cancers. However, they are not recommended for women with a history of blood clots, migraines with aura, or cardiovascular disease.
In short, combined hormonal contraceptives can be beneficial for certain women, but potential risks necessitate a careful health evaluation.
Progestin-Only Contraceptives (Mini-Pill, Shot, or Implant)
For those who cannot take estrogen, progestin-only methods may be a safer alternative, including:
- Mini-pill: Taken daily to prevent ovulation
- Depo-Provera shot: An injection every three months
- Hormonal implant: A small device inserted under the skin that releases progestin for up to three years
[Note: These methods are effective and do not carry the same clotting risks as estrogen-containing contraceptives. However, women with an active or recent (within five years) history of breast cancer should avoid these options.]
Progestin-only contraceptives can be an excellent choice for many, but a thorough discussion with a healthcare provider can confirm their suitability based on personal medical history.
Intrauterine Devices (IUDs)
IUDs or Intrauterine devices are placed inside the uterus and come in two main varieties:
- Hormonal IUDs (e.g., Mirena) that release progestin to lighten periods and reduce cramping (effective for 3–7 years)
- Copper IUDs (e.g., Paragard) that provide hormone-free contraception for up to 10 years, although they can cause heavier periods
Some women may need to avoid IUDs due to:
- Uterine cavity distortions
- Existing pelvic inflammatory disease
- Active chlamydial infection or gonorrhea
- Purulent cervicitis
In essence, IUDs offer long-lasting and effective contraception, but it is crucial to confirm that there are no contraindications before insertion.
Barrier Methods (Condoms, Diaphragms, and Cervical Caps)
Barrier methods provide non-hormonal options and can be used on demand. Condoms remain particularly important for women for reducing sexually transmitted infections (STIs), regardless of age.
Women experiencing vaginal dryness might need lubricants for comfort when using barriers. Thus, while barrier methods can be a good fit for those seeking hormone-free birth control, additional measures may be necessary to address dryness or discomfort.
Permanent Contraception (Sterilization)
If you are certain you no longer want children, tubal ligation (surgically “tying the tubes”) or a partner’s vasectomy can provide a highly effective, permanent solution. Permanent contraception relieves the ongoing need for birth control but is only suitable for those who have definitively concluded their family planning.
By reviewing each option’s pros and cons, you can determine which method aligns best with your current health requirements and long-term reproductive goals.
When to Stop Using Contraception
Many women are uncertain about when it is safe to discontinue birth control. This section clarifies the general guidelines for confirming menopause and discusses why stopping contraceptives too early can carry risks.
General Guidelines:
- If you are under 50, continue contraception for at least two years after your last menstrual period.
- If you are over 50, continue contraception for at least one year after your last menstrual period.
Continuing contraception long enough to confirm menopause helps avoid unintended pregnancy and ensures a smoother transition to this next life stage.
How to Confirm Menopause
A blood test measuring follicle-stimulating hormone (FSH) levels can help determine whether menopause has occurred, though contraceptives might affect the test’s accuracy. If you are taking hormonal contraception, one approach is to stop it for about a month, test FSH levels, and see if they exceed a threshold indicating non-fertility.
Since it can be challenging to pin down the exact onset of menopause while using hormonal methods, consulting a healthcare professional is essential before making any changes to your contraception routine.
When to See a Doctor
Despite the wide range of contraceptive options, you may face situations requiring medical support. This section highlights circumstances under which it is important to seek professional advice.
Side Effects from Contraceptives
Persistent headaches, high blood pressure, or clotting issues while on birth control may signal the need for an alternative option. Monitoring any new or worsening side effects and sharing them with a healthcare provider is crucial for your well-being.
Concerns About STI Risk
Sexually active individuals with new or multiple partners can benefit from regular STI screenings, regardless of menopausal status. Barrier methods also play an important role in STI prevention, so discussing these protective measures with a healthcare provider can be highly beneficial.
Consulting a doctor ensures that emerging symptoms, concerns about STIs, and lifestyle changes are addressed so that your chosen contraceptive method remains both safe and effective.
Conclusion
Menopause is a period of transition in a woman’s life, and contraception continues to be a key factor in health planning until menopause is definitively confirmed. Understanding how hormonal changes affect fertility, exploring appropriate birth control options, and knowing when it is safe to stop them can help ensure you make informed choices tailored to your unique needs.
If you are unsure about stopping contraception or experience problematic symptoms, it is advisable to consult a healthcare professional. Contraception during the menopausal transition is not solely about preventing pregnancy—it is also about safeguarding and enhancing overall health during this stage.
References
1. Tarlatzis, B. C. et al. (2003). Perimenopausal conception. Annals of the New York Academy of Sciences, 997, 93–104. https://doi.org/10.1196/annals.1290.011
2. Solymoss S. (2011). Risk of venous thromboembolism with oral contraceptives. CMAJ : Canadian Medical Association journal = journal de l’Association medicale canadienne, 183(18), E1278–E1279. https://doi.org/10.1503/cmaj.111614
3. Guerin, J. et al. (2022). Use of hormonal contraceptives in perimenopause: A systematic review. Pharmacotherapy, 42(2), 154–164. https://doi.org/10.1002/phar.2657
4. Grandi, G. et al. (2022). Contraception During Perimenopause: Practical Guidance. International journal of women’s health, 14, 913–929. https://doi.org/10.2147/IJWH.S288070
5. Harris, M. L. et al. (2021). Contraceptive use among women through their later reproductive years: Findings from an Australian prospective cohort study. PloS one, 16(8), e0255913. https://doi.org/10.1371/journal.pone.0255913
6. Cho M. K. (2018). Use of Combined Oral Contraceptives in Perimenopausal Women. Chonnam medical journal, 54(3), 153–158. https://doi.org/10.4068/cmj.2018.54.3.153
7. Bassuk, S. S. et al. (2015). Oral contraceptives and menopausal hormone therapy: relative and attributable risks of cardiovascular disease, cancer, and other health outcomes. Annals of epidemiology, 25(3), 193–200. https://doi.org/10.1016/j.annepidem.2014.11.004
8. Samson, M. et al. (2016). Progestin and breast cancer risk: a systematic review. Breast cancer research and treatment, 155(1), 3–12. https://doi.org/10.1007/s10549-015-3663-1
9. Harris, M. L. et al. (2021). Contraceptive use among women through their later reproductive years: Findings from an Australian prospective cohort study. PloS one, 16(8), e0255913. https://doi.org/10.1371/journal.pone.0255913
10. Maddox M. A. (1993). Contraceptive choices for perimenopausal women. Journal of the American Academy of Nurse Practitioners, 5(4), 181–182. https://doi.org/10.1111/j.1745-7599.1993.tb00868.x
11. Shaaban M. M. (1996). The perimenopause and contraception. Maturitas, 23(2), 181–192. https://doi.org/10.1016/0378-5122(96)83915-6
12. Baldwin, M. K. et al. (2013). Contraception during the perimenopause. Maturitas, 76(3), 235–242. https://doi.org/10.1016/j.maturitas.2013.07.009